Finance - Investment · Founded 2019 · www.maxindia.com · BSE 543223 · NSE MAXIND · ISIN INE0CG601016
No Notes Added Yet
Business
Max India Ltd. (MAXIND) operates primarily as an investment holding company within the finance sector in India. Its core business model involves holding significant stakes in other companies, managing these investments, and deriving value from their performance. Post a series of corporate restructurings, Max India Ltd. serves as the parent and holding company for Max Group's interests primarily in the healthcare and senior living sectors, with its main asset being a significant stake in Max Healthcare Institute Ltd. (MHIL) and its ownership of Antara Senior Living. It makes money through its share of profits from these investments, potential dividends from subsidiaries, and capital appreciation of its holdings.
Revenue Mix
Max India Ltd.'s primary assets and thus its segments are:
Healthcare (via Max Healthcare Institute Ltd. - MHIL): A significant stake in one of India's largest private healthcare providers, operating a network of hospitals across North India.
Senior Living (Antara Senior Living): This segment develops and manages communities for seniors, offering independent living, assisted living, and memory care, as well as providing related services.
While specific revenue contribution numbers are not available in the prompt, the performance of MHIL and Antara Senior Living directly impacts Max India Ltd.'s financial position and value.
Industry
Max India Ltd. operates as a financial investment company, but its underlying asset value and performance are intrinsically linked to the Indian healthcare and senior living industries. Within the broader finance sector, it acts as a strategic investor and holding company for the Max Group's ventures. Its positioning is bolstered by the established Max Group brand, which carries a legacy of trust and quality in India, and the strong market presence of its key subsidiary, Max Healthcare, as a leading player in the private healthcare sector. In senior living, Antara is positioned as an early mover and premium provider in a nascent but growing market.
MOAT
Max India Ltd.'s competitive advantages are primarily derived from its strategic investments:
Brand Reputation & Legacy: The Max Group brand carries significant trust and recognition in India, which benefits its underlying businesses like Max Healthcare and Antara Senior Living.
Scale & Network (Max Healthcare): Max Healthcare Institute Ltd. possesses a large network of hospitals, extensive infrastructure, and a reputable pool of medical professionals, creating operational efficiencies and brand loyalty.
Early Mover Advantage (Antara Senior Living): Antara has established itself in the niche and specialized senior living market in India, which requires significant capital, specific expertise, and trust, creating barriers to entry for new competitors.
Promoter Expertise: The Max Group promoters have a long track record of building and scaling businesses across diverse sectors.
Growth Drivers
Growth in Indian Healthcare Sector: Rising disposable incomes, increasing health awareness, a growing elderly population, and expanding health insurance coverage are tailwinds for Max Healthcare.
Demographic Shift & Urbanization: The increasing number of affluent elderly and changing family structures are driving demand for organized senior living solutions, benefiting Antara.
Expansion & Acquisition (within subsidiaries): Potential for Max Healthcare to expand its hospital network or service offerings, and for Antara to grow its senior living communities across more locations.
Value Unlocking: Strategic investments, asset monetization, or a re-rating of the holding company could unlock value for shareholders.
Risks
Performance of Key Holdings: Any underperformance, operational challenges, or intense competition faced by Max Healthcare or Antara Senior Living directly impacts Max India Ltd.'s value.
Regulatory Risks: The healthcare sector in India is subject to evolving regulations regarding pricing, quality standards, and ethical practices, which can impact profitability. Senior living also faces emerging regulatory frameworks.
Economic Downturn: A general economic slowdown could reduce discretionary spending on healthcare services and demand for premium senior living offerings.
Holding Company Discount: Investment holding companies often trade at a discount to the sum of their underlying assets due to various factors like lack of direct control over subsidiaries' cash flows, opacity, and overheads.
Competition: Increased competition in both healthcare (from other large hospital chains) and senior living (as more players enter the market) could impact profitability and market share.
Management & Ownership
Max India Ltd. is part of the well-known Max Group, which has a long-standing presence in the Indian business landscape. The promoter group, led by Analjit Singh, retains a significant ownership stake, indicating strong alignment between management and shareholder interests. The group generally comprises experienced professionals at the helm of its various businesses, contributing to strategic direction and operational efficiency. The ownership structure includes both promoter holding and public shareholders.
Outlook
Max India Ltd. presents a mixed outlook, characteristic of an investment holding company with strong underlying assets. The bull case rests on the robust growth prospects of the Indian healthcare sector and the nascent but high-potential senior living market. Max Healthcare, as a market leader, is well-positioned to capitalize on increasing demand, while Antara Senior Living benefits from an early-mover advantage in a demographic megatrend. Successful expansion and improved profitability of these core holdings could significantly enhance Max India Ltd.'s intrinsic value and potentially lead to a re-rating or narrowing of the holding company discount.
However, the bear case considers the inherent challenges. The company's valuation is largely tied to its holdings, especially Max Healthcare, which operates in a competitive and highly regulated environment. Any slowdown in the healthcare sector, unforeseen regulatory changes, or increased competition could impact its performance. Furthermore, investment holding companies often trade at a discount, and overcoming this "holding company discount" can be challenging. While the potential for value creation from its quality assets is present, investors must factor in the indirect nature of its earnings and the risks associated with its primary investments.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 45 | 26 | 43 | 35 | 42 | 37 | 45 | 43 | 66 | 60 |
| Other Income | 5 | 6 | 5 | 4 | 4 | 5 | 5 | 7 | 6 | 9 |
| Total Income | 50 | 32 | 47 | 39 | 45 | 41 | 50 | 50 | 72 | 69 |
| Total Expenditure | 65 | 54 | 64 | 64 | 81 | 65 | 75 | 78 | 79 | 94 |
| Operating Profit | -15 | -22 | -16 | -25 | -36 | -23 | -25 | -28 | -7 | -25 |
| Interest | 1 | 1 | 2 | 2 | 3 | 4 | 4 | 3 | 3 | 3 |
| Depreciation | 3 | 4 | 5 | 5 | 5 | 6 | 6 | 6 | 7 | 7 |
| Exceptional Income / Expenses | 0 | 0 | 0 | -13 | -0 | 8 | -0 | -3 | -0 | -0 |
| Profit Before Tax | -20 | -28 | -23 | -45 | -44 | -25 | -35 | -40 | -17 | -35 |
| Provision for Tax | 1 | 0 | 1 | 0 | 1 | 1 | -2 | 1 | 0 | 1 |
| Profit After Tax | -21 | -28 | -23 | -45 | -45 | -26 | -33 | -42 | -18 | -36 |
| Adjustments | -1 | 1 | 1 | 1 | -1 | -0 | -1 | -1 | -2 | -1 |
| Profit After Adjustments | -22 | -27 | -23 | -45 | -46 | -26 | -34 | -43 | -19 | -36 |
| Adjusted Earnings Per Share | -4.7 | -5.9 | -5 | -9.8 | -10 | -4.9 | -6.5 | -8.2 | -3.7 | -6.9 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Net Sales | 211 | 121 | 230 | 201 | 176 | 145 | 191 | 214 |
| Other Income | 3 | 9 | 8 | 12 | 19 | 19 | 23 | 27 |
| Total Income | 214 | 130 | 237 | 213 | 195 | 164 | 213 | 241 |
| Total Expenditure | 216 | 150 | 231 | 201 | 230 | 264 | 296 | 326 |
| Operating Profit | -2 | -20 | 6 | 13 | -35 | -100 | -83 | -85 |
| Interest | 27 | 24 | 10 | 6 | 5 | 8 | 14 | 13 |
| Depreciation | 8 | 10 | 7 | 8 | 10 | 19 | 25 | 26 |
| Exceptional Income / Expenses | -50 | -8 | -5 | 0 | 0 | -13 | 5 | -3 |
| Profit Before Tax | -87 | -63 | -18 | -3 | -49 | -139 | -121 | -127 |
| Provision for Tax | 5 | -11 | -2 | 7 | 7 | 2 | 1 | 0 |
| Profit After Tax | -93 | -52 | -16 | -10 | -56 | -140 | -122 | -129 |
| Adjustments | 0 | 1 | 0 | 0 | 0 | 0 | 0 | -5 |
| Profit After Adjustments | -93 | -52 | -16 | -10 | -56 | -140 | -122 | -132 |
| Adjusted Earnings Per Share | -16.3 | -9.1 | -2.8 | -2.3 | -12.3 | -30.4 | -23.2 | -25.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 32% | -2% | 10% | 0% |
| Operating Profit CAGR | 0% | NAN% | 0% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -28% | 5% | 17% | NA% |
| ROE Average | -34% | -26% | -17% | -15% |
| ROCE Average | -28% | -22% | -13% | -11% |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 706 | 653 | 641 | 542 | 492 | 359 | 408 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 136 | 87 | 39 | 22 | 1 | 1 | 1 |
| Other Non-Current Liabilities | 19 | 31 | 24 | 28 | 52 | 108 | 97 |
| Total Current Liabilities | 162 | 226 | 153 | 161 | 139 | 165 | 162 |
| Total Liabilities | 1023 | 996 | 857 | 753 | 684 | 633 | 668 |
| Fixed Assets | 144 | 156 | 90 | 91 | 125 | 170 | 195 |
| Other Non-Current Assets | 59 | 112 | 218 | 203 | 216 | 107 | 93 |
| Total Current Assets | 819 | 728 | 549 | 459 | 343 | 260 | 381 |
| Total Assets | 1023 | 996 | 857 | 753 | 684 | 633 | 668 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 60 | 12 | 24 | 14 | 89 | 116 | 23 |
| Cash Flow from Operating Activities | -19 | 73 | 66 | 69 | -102 | -128 | -95 |
| Cash Flow from Investing Activities | -586 | 13 | 18 | 124 | 159 | 47 | -50 |
| Cash Flow from Financing Activities | 557 | -73 | -94 | -119 | -29 | -13 | 148 |
| Net Cash Inflow / Outflow | -48 | 12 | -10 | 75 | 27 | -93 | 4 |
| Closing Cash & Cash Equivalent | 12 | 24 | 14 | 89 | 116 | 23 | 27 |
| # | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -16.26 | -9.06 | -2.83 | -2.28 | -12.34 | -30.42 | -23.2 |
| CEPS(Rs) | -14.79 | -7.37 | -1.59 | -0.43 | -10.11 | -26.34 | -18.42 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 123.91 | 114.71 | 112.4 | 118.21 | 105.76 | 75.52 | 68.23 |
| Core EBITDA Margin(%) | -2.49 | -23.74 | -0.54 | 0.25 | -30.99 | -81.24 | -55.55 |
| EBIT Margin(%) | -28.57 | -31.95 | -3.37 | 1.6 | -25.26 | -89.71 | -56.24 |
| Pre Tax Margin(%) | -41.41 | -52.14 | -7.84 | -1.5 | -27.92 | -95.25 | -63.48 |
| PAT Margin (%) | -43.89 | -43.32 | -7.02 | -5.16 | -32.1 | -96.5 | -63.94 |
| Cash Profit Margin (%) | -39.93 | -34.74 | -3.94 | -0.96 | -26.32 | -83.56 | -50.77 |
| ROA(%) | -9.05 | -5.19 | -1.74 | -1.29 | -7.84 | -21.32 | -18.74 |
| ROE(%) | -13.12 | -7.71 | -2.5 | -1.76 | -11.03 | -33.75 | -34.48 |
| ROCE(%) | -6.88 | -4.68 | -1.06 | 0.52 | -8.39 | -30.58 | -27.83 |
| Receivable days | 24.36 | 32.46 | 10.42 | 7.78 | 8.1 | 33.9 | 56.68 |
| Inventory Days | 391.16 | 717.86 | 301.46 | 164.65 | 59.37 | 28.56 | 30.8 |
| Payable days | 153.81 | 579.52 | 49.64 | 44.5 | 108.15 | 304.14 | 225.74 |
| PER(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0.53 | 0.62 | 0.65 | 1.77 | 2.3 | 1.8 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 1.01 | 3.67 | 1.8 | 1.4 | 3.68 | 4.77 | 2.99 |
| EV/Core EBITDA(x) | -109.75 | -22.21 | 65.56 | 21.77 | -18.28 | -6.98 | -6.87 |
| Net Sales Growth(%) | 0 | -42.71 | 90.17 | -12.55 | -12.64 | -17.16 | 30.98 |
| EBIT Growth(%) | 0 | 35.94 | 79.94 | 141.54 | -1478.74 | -194.18 | 17.88 |
| PAT Growth(%) | 0 | 43.45 | 69.18 | 35.65 | -442.97 | -149.03 | 13.21 |
| EPS Growth(%) | 0 | 44.26 | 68.73 | 19.57 | -441.19 | -146.63 | 23.75 |
| Debt/Equity(x) | 0.24 | 0.19 | 0.06 | 0.04 | 0 | 0 | 0 |
| Current Ratio(x) | 5.07 | 3.22 | 3.59 | 2.84 | 2.47 | 1.58 | 2.35 |
| Quick Ratio(x) | 3.67 | 2.12 | 2.73 | 2.53 | 2.43 | 1.48 | 2.26 |
| Interest Cover(x) | -2.23 | -1.58 | -0.75 | 0.52 | -9.51 | -16.19 | -7.77 |
| Total Debt/Mcap(x) | 0 | 0.35 | 0.1 | 0.06 | 0 | 0 | 0 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 50.94 | 50.94 | 50.94 | 50.45 | 50.16 | 50.05 | 49.89 | 49.82 | 49.77 | 48.22 |
| FII | 9.01 | 7.41 | 6.77 | 6.63 | 7.13 | 7.08 | 7.08 | 7.07 | 7.06 | 6.89 |
| DII | 0.81 | 0.81 | 0.94 | 0.81 | 0.98 | 1.43 | 1.58 | 1.62 | 1.66 | 4.94 |
| Public | 39.24 | 40.84 | 41.35 | 42.11 | 41.73 | 41.44 | 41.45 | 41.48 | 41.52 | 39.95 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.2 | 2.2 | 2.2 | 2.2 | 2.62 | 2.62 | 2.62 | 2.62 | 2.62 | 2.72 |
| FII | 0.39 | 0.32 | 0.29 | 0.29 | 0.37 | 0.37 | 0.37 | 0.37 | 0.37 | 0.39 |
| DII | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | 0.07 | 0.08 | 0.09 | 0.09 | 0.28 |
| Public | 1.69 | 1.76 | 1.78 | 1.84 | 2.18 | 2.17 | 2.17 | 2.18 | 2.18 | 2.25 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4.32 | 4.32 | 4.32 | 4.36 | 5.22 | 5.23 | 5.25 | 5.25 | 5.26 | 5.63 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +32% | -2% | +10% | — |
| Operating Profit CAGR | — | 0% | — | — |
| PAT CAGR | — | — | — | — |
| Share Price CAGR | -28% | +5% | +17% | — |
| ROE Average | -34% | -26% | -17% | -15% |
| ROCE Average | -28% | -22% | -13% | -11% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 50.94 | 50.94 | 50.94 | 50.45 | 50.16 | 50.05 | 49.89 | 49.82 | 49.77 | 48.22 |
| FII | 9.01 | 7.41 | 6.77 | 6.63 | 7.13 | 7.08 | 7.08 | 7.07 | 7.06 | 6.89 |
| DII | 0.81 | 0.81 | 0.94 | 0.81 | 0.98 | 1.43 | 1.58 | 1.62 | 1.66 | 4.94 |
| Public | 39.24 | 40.84 | 41.35 | 42.11 | 41.73 | 41.44 | 41.45 | 41.48 | 41.52 | 39.95 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.2 | 2.2 | 2.2 | 2.2 | 2.62 | 2.62 | 2.62 | 2.62 | 2.62 | 2.72 |
| FII | 0.39 | 0.32 | 0.29 | 0.29 | 0.37 | 0.37 | 0.37 | 0.37 | 0.37 | 0.39 |
| DII | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | 0.07 | 0.08 | 0.09 | 0.09 | 0.28 |
| Public | 1.69 | 1.76 | 1.78 | 1.84 | 2.18 | 2.17 | 2.17 | 2.18 | 2.18 | 2.25 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4.32 | 4.32 | 4.32 | 4.36 | 5.22 | 5.23 | 5.25 | 5.25 | 5.26 | 5.63 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.